Literature DB >> 26280855

Short versus standard duration tourniquet use during Total Knee Replacement: A pilot study.

Santoshkumar Hakkalamani, Vicki Clark, Nikhil Pradhan.   

Abstract

We performed a prospective, randomized, controlled trial to know whether a short duration of tourniquet application affects surgical time, post-operative swelling, pain, early rehabilitation and complications compared to standard use of tourniquet throughout the procedure. Sixty knees were randomized. There were no differences in terms of surgical time and pain experienced between the two groups. Patients in the short duration tourniquet group had significantly less thigh swelling (3.7±1.6 versus 4.8±2.35 p<0.01). There were no differences in the early rehabilitation between the groups. Soft tissue complications were higher in standard duration group. The use of tourniquet only during cementation of the implants reduces the thigh swelling and soft tissue complications associated with tourniquet use throughout the procedure.

Entities:  

Mesh:

Year:  2015        PMID: 26280855

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  3 in total

Review 1.  Effectiveness and Safety of Tourniquet Application Strategies in Total Knee Arthroplasty: a Meta-analysis.

Authors:  Yi-Xiang He; Wan-Jia Qiao; Yu-Hao Zhao; Zhao Gao; Wen-Ji Wang
Journal:  Indian J Orthop       Date:  2021-07-02       Impact factor: 1.033

2.  Comparison of tourniquet application only during cementation and long-duration tourniquet application in total knee arthroplasty: a meta-analysis.

Authors:  Cong Wang; Chenhe Zhou; Hao Qu; Shigui Yan; Zhijun Pan
Journal:  J Orthop Surg Res       Date:  2018-08-30       Impact factor: 2.359

3.  Comparison of efficacy and safety of different tourniquet applications in total knee arthroplasty: a network meta-analysis of randomized controlled trials.

Authors:  Ziqin Cao; Jia Guo; Qiangxiang Li; Jianhuang Wu; Yajia Li
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.